Filtered By:
Education: Study
Management: Healthcare Costs

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 188 results found since Jan 2013.

Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke: Current Evidence Clinical Sciences
Conclusions— Our analysis supports earlier economic evaluations that r-tPA is a cost-effective method to treat stroke. Appropriate use of r-tPA should be prioritized nationally.
Source: Stroke - September 22, 2014 Category: Neurology Authors: Boudreau, D. M., Guzauskas, G. F., Chen, E., Lalla, D., Tayama, D., Fagan, S. C., Veenstra, D. L. Tags: Emergency treatment of Stroke, Thrombolysis Clinical Sciences Source Type: research

Trimming the fat in acute ischemic stroke: an assessment of 24‐h CT scans in tPA patients
ConclusionsOur results demonstrate that routine 24‐h computed tomography scan in patients without 24‐h National Institute of Health Stroke Scale worsening (especially those with baseline National Institute of Health Stroke Scale ≤10) is less likely to yield information that results in a deviation from standard acute stroke care. No patient without worsening and baseline National Institute of Health Stroke Scale ≤10 had parenchymal hematoma on 24‐h computed tomography. Application of the National Institute of Health Stroke Scale to distinguish patients who should have 24‐h follow‐up imaging from those who will...
Source: International Journal of Stroke - June 3, 2014 Category: Neurology Authors: Alexander J. George, Amelia K. Boehme, Casey R. Dunn, T. Beasley, James E. Siegler, Karen C. Albright, Ramy El Khoury, Sheryl Martin‐Schild Tags: Research Source Type: research

Impact of Atrial Fibrillation on Stroke-Related Healthcare Costs Stroke
Conclusion Stroke-related care for IS, HS, and TIA is costly, especially among individuals with AF. Reducing the risk of AF-related stroke is important from both clinical and economic standpoints.
Source: JAHA:Journal of the American Heart Association - November 25, 2013 Category: Cardiology Authors: Sussman, M., Menzin, J., Lin, I., Kwong, W. J., Munsell, M., Friedman, M., Selim, M. Tags: Stroke Source Type: research

The iScore predicts total healthcare costs early after hospitalization for an acute ischemic stroke
ConclusionsThe ischemic Stroke risk score can be useful as a predictor of healthcare utilization and costs early after hospitalization for an acute ischemic stroke.
Source: International Journal of Stroke - October 27, 2015 Category: Neurology Authors: Emmanuel M. Ewara, Wanrudee Isaranuwatchai, Dawn M. Bravata, Linda S. Williams, Jiming Fang, Jeffrey S. Hoch, Gustavo Saposnik, Tags: Research Source Type: research

Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke: Experience From Australian Stroke Center Clinical Sciences
Conclusions— Intravenous tPA within 4.5 hours represents a cost-effective intervention for acute ischemic stroke.
Source: Stroke - July 22, 2013 Category: Neurology Authors: Tan Tanny, S. P., Busija, L., Liew, D., Teo, S., Davis, S. M., Yan, B. Tags: Thrombolysis Clinical Sciences Source Type: research

Quantified health and cost effects of faster endovascular treatment for large vessel ischemic stroke patients in the Netherlands
Conclusion One-minute faster EVT increases QALYs while cumulative costs remain largely unaffected. Therefore, faster EVT provides better value of care at no extra healthcare costs.
Source: Journal of NeuroInterventional Surgery - November 18, 2021 Category: Neurosurgery Authors: van Voorst, H., Kunz, W. G., van den Berg, L. A., Kappelhof, M., Pinckaers, F. M. E., Goyal, M., Hunink, M. G. M., Emmer, B. J., Mulder, M. J. H. L., Dippel, D. W. J., Coutinho, J. M., Marquering, H. A., Boogaarts, H. D., van der Lugt, A., van Zwam, W. H. Tags: Open access, Ischemic stroke Source Type: research

Dysphagia-related acute stroke complications: A retrospective observational cohort study
Dysphagia, or impaired swallowing, is reported to affect between 8.1% and 45.3% of patients following stroke.1 Dysphagia is associated with longer length of stay (LOS) in acute hospital, increased healthcare costs, and greater long-term institutionalisation.2,3 Aspiration pneumonia mediates a significant proportion of this deleterious association and, in its own right, is associated with increased length of stay in hospital,4 poorer post-stroke functioning,5,6 and increased mortality.7
Source: Journal of Stroke and Cerebrovascular Diseases - April 12, 2023 Category: Neurology Authors: Verity E. Bond, Sebastian Doeltgen, Timothy Kleinig, Joanne Murray Source Type: research

Healthcare costs before and after stroke in non-valvular atrial fibrillation patients who initiated treatment with rivaroxaban or warfarin.
CONCLUSIONS: Total all-cause costs of care increased in the post-stroke period, and particularly in the patients treated with warfarin relative to those treated with rivaroxaban. The lower rate of stroke in the rivaroxaban cohort suggests that greater pre- to post-stroke cost increases result from more strokes occurring in the warfarin cohort. PMID: 33499689 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - January 29, 2021 Category: Health Management Tags: J Med Econ Source Type: research

Abstract 301: Healthcare Costs Following Stroke and Major Bleeding Events in Nonvalvular Atrial Fibrillation Patients Session Title: Poster Session III
Conclusions: NVAF patients who have a stroke or MB event incur higher healthcare costs relative to patients without events. Interventions preventing stroke or MB events have the potential to reduce the healthcare burden associated NVAF.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Naccarelli, G., Stokes, M., DeLeon, A., Tate, N., Wang, R., Wang, A., Fredell, J. Tags: Session Title: Poster Session III Source Type: research

Evaluation of the Influence of Etiological Factors on the Economic Burden of Ischemic Stroke in Younger Patients in China Using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Classification.
CONCLUSIONS In the younger patient population in China, etiological factors influenced the economic burden of ischemic stroke. PMID: 30666992 [PubMed - in process]
Source: Medical Science Monitor - January 24, 2019 Category: Research Tags: Med Sci Monit Source Type: research

Seizures and Epilepsy after Stroke: Resources and Costs Assessment (P03.118)
CONCLUSIONS: Seizures after stroke substantially increase direct costs and resource consumption. They contribute to poor prognosis of stroke and increases mortality.Disclosure: Dr. Guekht has nothing to disclose. Dr. Mizinova has nothing to disclose. Dr. Ershov has nothing to disclose. Dr. Guz has nothing to disclose. Dr. Kaimovsky has nothing to disclose. Dr. Shpak has nothing to disclose.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Guekht, A., Mizinova, M., Ershov, A., Guz, D., Kaimovsky, I., Shpak, A. Tags: P03 Epilepsy: Resources, Quality Measures, and Epidemiology Source Type: research

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
CONCLUSIONS SSRIs appeared to improve dependence, disability, neurological impairment, anxiety and depression after stroke, but there was heterogeneity between trials and methodological limitations in a substantial proportion of the trials. Large, well-designed trials are now needed to determine whether SSRIs should be given routinely to patients with stroke. PMID: 23903272 [PubMed - in process]
Source: Sao Paulo Medical Journal - August 3, 2013 Category: Journals (General) Authors: Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hacklett ML Tags: Sao Paulo Med J Source Type: research

CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment
IRVINE, CA – September 9, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies* today announced that it has launched CERENOVUS Stroke Solutions™, which includes a suite of three devices designed to aid physicians in clot removal procedures. The announcement was made during the virtual European Society of Minimally Invasive Neurological Therapy (ESMINT).Strokes are the second leading cause of death globally, and account for an estimated 140,000 deaths in the United States each year.[i],[ii] Over half of stroke survivors become chronically disabled placing an estimated $34 billion economic burden o...
Source: Johnson and Johnson - September 9, 2020 Category: Pharmaceuticals Source Type: news

Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease
Conclusion: Having stroke, MI, or PAD was associated with increases in HCRU and costs in patients with T2DM. Although PAD was associated with smaller per patient increases in total healthcare costs than patients with T2DM + stroke/MI, the higher frequency of incident PAD may make it more costly than MI or stroke in a large population of patients with T2DM.PMID:36134459 | DOI:10.1080/03007995.2022.2125259
Source: Current Medical Research and Opinion - September 22, 2022 Category: Research Authors: Aaron King Jigar Rajpura Yuanjie Liang Yurek Paprocki Chioma Uzoigwe Source Type: research